Elham Masoumi
- Immunology top 10%
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 3
- Oncology top 10%
- CAR-T cell therapy research 8
- Cancer Immunotherapy and Biomarkers 2
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 3
-
- Pregnancy and preeclampsia studies 2
-
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Leila JafarzadehJamshid HadjatiKeyvan Fallah-MehrjardiHamid Reza MirzaeiSeyed Amir JalaliJalil Tavakkol‐AfshariMahmoud Reza JaafariSeyed‐Alireza Esmaeili
- Partner nations
- IranUnited StatesGermany
In The Last Decade
Elham Masoumi
25 papers receiving 689 citations
Peers
Comparison fields: 5 of 89
- Immunology 239
- Oncology 291
- Infectious Diseases 97
- Molecular Biology 289
- Neurology 58
Countries citing papers authored by Elham Masoumi
This map shows the geographic impact of Elham Masoumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Masoumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Masoumi more than expected).
Fields of papers citing papers by Elham Masoumi
This network shows the impact of papers produced by Elham Masoumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Masoumi. The network helps show where Elham Masoumi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elham Masoumi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 12 | |
| 4 | 2022 | 44 | |
| 5 | 2022 | 76 | |
| 6 | 2021 | 25 | |
| 7 | 2021 | 27 | |
| 8 | 2021 | 29 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 22 | |
| 11 | 2021 | 4 | |
| 12 | 2020 | 26 | |
| 13 | 2020 | 6 | |
| 14 | 2020 | 11 | |
| 15 | 2018 | 34 | |
| 16 | 2017 | 7 | |
| 17 | Methylprednisolone versus Dexamethasone for Control of Vertigo in Patients with Definite Meniere's disease. | 2017 | 10 |
| 18 | 2016 | 7 | |
| 19 | 2015 | 131 | |
| 20 | 2013 | 7 |
About Elham Masoumi
Elham Masoumi is a scholar working on Immunology, Oncology and Obstetrics and Gynecology, having authored 26 papers that have together received 701 indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (6 papers), COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Immunotherapy and Immune Responses (3 papers), Pregnancy and preeclampsia studies (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Immunology (239 citations), Oncology (291 citations) and Infectious Diseases (97 citations). Elham Masoumi has collaborated with scholars based in Iran, United States and Germany. Frequent co-authors include Leila Jafarzadeh, Jamshid Hadjati, Keyvan Fallah-Mehrjardi, Hamid Reza Mirzaei, Seyed Amir Jalali, Jalil Tavakkol‐Afshari, Mahmoud Reza Jaafari, Seyed‐Alireza Esmaeili, Farshid Noorbakhsh and Leila Mobasheri.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.